Table 1

Baseline demographic and immunological parameters of study participants

Parameters

HIV/HCV

co-infection

HIV

mono-infection

HCV

mono-infection

Healthy control

Number

20

20

10

10

Sex ratio (male/female)

13/7

12/8

7/3

4/6

Age (years)

39.00

(35.25 ~ 41.50) ^{c, d}

37.00

(32.75 ~ 41.50) ^{c, d}

45.50

(39.50 ~ 48.50) ^{a, b, d}

26.50

(25.00 ~ 29.25) ^{a, b, c}

Transmission route

(no. (%))

Sex

0 (0)

12 (60)

0 (0)

-

Blood

4 (20)

1 (5)

10 (100)

-

IDU

16 (80)

4 (20)

0 (0)

-

Unknown

0 (0)

3 (15)

0 (0)

-

CD4 T cell count (cells/μl)

224.00

(164.00 ~ 296.00) ^{b, c, d}

131.00

(73.75 ~ 194.50) ^{a, c, d}

522.50

(448.00 ~ 599.00) ^{a, b, d}

817.00 (736.00 ~ 947.25) ^{a, b, c}

HIV-1 Viral load

(log₁₀ copies/ml)

3.97(3.48 ~ 4.83) ^b

4.65(4.38 ~ 5.23) ^a

-

-

HCV Viral load

(log₁₀ copies/ml)

6.42(5.91 ~ 6.85)

-

6.05(5.33 ~ 6.54)

-

a. p < 0.05 difference when compared to HIV/HCV co-infection

b. p < 0.05 difference when compared to HIV mono-infection

c. p < 0.05 difference when compared to HCV mono-infection

d. p < 0.05 difference when compared to healthy control

Kang et al. BMC Infectious Diseases 2012 12:102   doi:10.1186/1471-2334-12-102